Longitudinal studies of cerebral glucose metabolism in late-life depression and normal aging

Christopher M. Marano, Clifford I. Workman, Elisse Kramer, Carol R. Hermann, Yilong Ma, Vijay Dhawan, Thomas Chaly, David Eidelberg, Gwenn Smith

Research output: Contribution to journalArticle

Abstract

Objective Late-life depression (LLD) has a substantial public health impact and is both a risk factor for and a prodrome of dementia. Positron emission tomography (PET) studies of cerebral glucose metabolism have demonstrated sensitivity in evaluating neural circuitry involved in depression, aging, incipient cognitive decline, and dementia. The present study evaluated the long term effects of a course of antidepressant treatment on glucose metabolism in LLD patients. Methods Nine LLD patients and seven non-depressed control subjects underwent clinical and cognitive evaluations as well as brain magnetic resonance imaging and PET studies of cerebral glucose metabolism at baseline, after 8 weeks of treatment with citalopram for a major depressive episode (patients only), and at an approximately 2-year follow-up. Results The majority of LLD patients were remitted at follow-up (7/9). Neither patients nor controls showed significant cognitive decline. The patients showed greater increases in glucose metabolism than the controls in regions associated with mood symptoms (anterior cingulate and insula). Both groups showed decreases in metabolism in posterior association cortices implicated in dementia. Conclusions Longitudinal changes in cerebral glucose metabolism are observed in controls and in LLD patients without significant cognitive decline that are more extensive than the decreases in brain volume. Longer duration follow-up studies and the integration of other molecular imaging methods will have implications for understanding the clinical and neurobiological significance of these metabolic changes.

Original languageEnglish (US)
Pages (from-to)417-423
Number of pages7
JournalInternational Journal of Geriatric Psychiatry
Volume28
Issue number4
DOIs
StatePublished - Apr 2013

Fingerprint

Longitudinal Studies
Depression
Glucose
Dementia
Positron-Emission Tomography
Citalopram
Molecular Imaging
Gyrus Cinguli
Brain
Antidepressive Agents
Public Health
Magnetic Resonance Imaging
Therapeutics
Cognitive Dysfunction

Keywords

  • aging
  • cerebral glucose metabolism
  • citalopram
  • late-life depression
  • PET

ASJC Scopus subject areas

  • Geriatrics and Gerontology
  • Psychiatry and Mental health

Cite this

Longitudinal studies of cerebral glucose metabolism in late-life depression and normal aging. / Marano, Christopher M.; Workman, Clifford I.; Kramer, Elisse; Hermann, Carol R.; Ma, Yilong; Dhawan, Vijay; Chaly, Thomas; Eidelberg, David; Smith, Gwenn.

In: International Journal of Geriatric Psychiatry, Vol. 28, No. 4, 04.2013, p. 417-423.

Research output: Contribution to journalArticle

Marano, CM, Workman, CI, Kramer, E, Hermann, CR, Ma, Y, Dhawan, V, Chaly, T, Eidelberg, D & Smith, G 2013, 'Longitudinal studies of cerebral glucose metabolism in late-life depression and normal aging', International Journal of Geriatric Psychiatry, vol. 28, no. 4, pp. 417-423. https://doi.org/10.1002/gps.3840
Marano, Christopher M. ; Workman, Clifford I. ; Kramer, Elisse ; Hermann, Carol R. ; Ma, Yilong ; Dhawan, Vijay ; Chaly, Thomas ; Eidelberg, David ; Smith, Gwenn. / Longitudinal studies of cerebral glucose metabolism in late-life depression and normal aging. In: International Journal of Geriatric Psychiatry. 2013 ; Vol. 28, No. 4. pp. 417-423.
@article{c47b062cfb634835a6d1432fca6b017c,
title = "Longitudinal studies of cerebral glucose metabolism in late-life depression and normal aging",
abstract = "Objective Late-life depression (LLD) has a substantial public health impact and is both a risk factor for and a prodrome of dementia. Positron emission tomography (PET) studies of cerebral glucose metabolism have demonstrated sensitivity in evaluating neural circuitry involved in depression, aging, incipient cognitive decline, and dementia. The present study evaluated the long term effects of a course of antidepressant treatment on glucose metabolism in LLD patients. Methods Nine LLD patients and seven non-depressed control subjects underwent clinical and cognitive evaluations as well as brain magnetic resonance imaging and PET studies of cerebral glucose metabolism at baseline, after 8 weeks of treatment with citalopram for a major depressive episode (patients only), and at an approximately 2-year follow-up. Results The majority of LLD patients were remitted at follow-up (7/9). Neither patients nor controls showed significant cognitive decline. The patients showed greater increases in glucose metabolism than the controls in regions associated with mood symptoms (anterior cingulate and insula). Both groups showed decreases in metabolism in posterior association cortices implicated in dementia. Conclusions Longitudinal changes in cerebral glucose metabolism are observed in controls and in LLD patients without significant cognitive decline that are more extensive than the decreases in brain volume. Longer duration follow-up studies and the integration of other molecular imaging methods will have implications for understanding the clinical and neurobiological significance of these metabolic changes.",
keywords = "aging, cerebral glucose metabolism, citalopram, late-life depression, PET",
author = "Marano, {Christopher M.} and Workman, {Clifford I.} and Elisse Kramer and Hermann, {Carol R.} and Yilong Ma and Vijay Dhawan and Thomas Chaly and David Eidelberg and Gwenn Smith",
year = "2013",
month = "4",
doi = "10.1002/gps.3840",
language = "English (US)",
volume = "28",
pages = "417--423",
journal = "International Journal of Geriatric Psychiatry",
issn = "0885-6230",
publisher = "John Wiley and Sons Ltd",
number = "4",

}

TY - JOUR

T1 - Longitudinal studies of cerebral glucose metabolism in late-life depression and normal aging

AU - Marano, Christopher M.

AU - Workman, Clifford I.

AU - Kramer, Elisse

AU - Hermann, Carol R.

AU - Ma, Yilong

AU - Dhawan, Vijay

AU - Chaly, Thomas

AU - Eidelberg, David

AU - Smith, Gwenn

PY - 2013/4

Y1 - 2013/4

N2 - Objective Late-life depression (LLD) has a substantial public health impact and is both a risk factor for and a prodrome of dementia. Positron emission tomography (PET) studies of cerebral glucose metabolism have demonstrated sensitivity in evaluating neural circuitry involved in depression, aging, incipient cognitive decline, and dementia. The present study evaluated the long term effects of a course of antidepressant treatment on glucose metabolism in LLD patients. Methods Nine LLD patients and seven non-depressed control subjects underwent clinical and cognitive evaluations as well as brain magnetic resonance imaging and PET studies of cerebral glucose metabolism at baseline, after 8 weeks of treatment with citalopram for a major depressive episode (patients only), and at an approximately 2-year follow-up. Results The majority of LLD patients were remitted at follow-up (7/9). Neither patients nor controls showed significant cognitive decline. The patients showed greater increases in glucose metabolism than the controls in regions associated with mood symptoms (anterior cingulate and insula). Both groups showed decreases in metabolism in posterior association cortices implicated in dementia. Conclusions Longitudinal changes in cerebral glucose metabolism are observed in controls and in LLD patients without significant cognitive decline that are more extensive than the decreases in brain volume. Longer duration follow-up studies and the integration of other molecular imaging methods will have implications for understanding the clinical and neurobiological significance of these metabolic changes.

AB - Objective Late-life depression (LLD) has a substantial public health impact and is both a risk factor for and a prodrome of dementia. Positron emission tomography (PET) studies of cerebral glucose metabolism have demonstrated sensitivity in evaluating neural circuitry involved in depression, aging, incipient cognitive decline, and dementia. The present study evaluated the long term effects of a course of antidepressant treatment on glucose metabolism in LLD patients. Methods Nine LLD patients and seven non-depressed control subjects underwent clinical and cognitive evaluations as well as brain magnetic resonance imaging and PET studies of cerebral glucose metabolism at baseline, after 8 weeks of treatment with citalopram for a major depressive episode (patients only), and at an approximately 2-year follow-up. Results The majority of LLD patients were remitted at follow-up (7/9). Neither patients nor controls showed significant cognitive decline. The patients showed greater increases in glucose metabolism than the controls in regions associated with mood symptoms (anterior cingulate and insula). Both groups showed decreases in metabolism in posterior association cortices implicated in dementia. Conclusions Longitudinal changes in cerebral glucose metabolism are observed in controls and in LLD patients without significant cognitive decline that are more extensive than the decreases in brain volume. Longer duration follow-up studies and the integration of other molecular imaging methods will have implications for understanding the clinical and neurobiological significance of these metabolic changes.

KW - aging

KW - cerebral glucose metabolism

KW - citalopram

KW - late-life depression

KW - PET

UR - http://www.scopus.com/inward/record.url?scp=84874729453&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84874729453&partnerID=8YFLogxK

U2 - 10.1002/gps.3840

DO - 10.1002/gps.3840

M3 - Article

C2 - 22740289

AN - SCOPUS:84874729453

VL - 28

SP - 417

EP - 423

JO - International Journal of Geriatric Psychiatry

JF - International Journal of Geriatric Psychiatry

SN - 0885-6230

IS - 4

ER -